Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Aug 4:7:2049936120947517.
doi: 10.1177/2049936120947517. eCollection 2020 Jan-Dec.

Chloroquine and hydroxychloroquine as a repurposed agent against COVID-19: a narrative review

Yogesh Acharya  1 , Abida Sayed  2
Affiliations
Review

Chloroquine and hydroxychloroquine as a repurposed agent against COVID-19: a narrative review

Yogesh Acharya et al. Ther Adv Infect Dis. .

Abstract

The predicament arising from the coronavirus disease 2019 (COVID-19) pandemic has become one of the most significant modern public health challenges. Despite uncertainties in the viral determinants and pathogenesis, it is crucial to accurately inspect all available evidence to construct accurate clinical guidelines for optimised patient care. This study aims to discuss the available evidence for the use of chloroquine (CQ) and hydroxychloroquine (HCQ) against COVID-19. Early in vitro studies of CQ/HCQ against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are convincing. But contradictory evidence exists on the clinical use of CQ/HCQ, either alone or in combination with azithromycin. As of now, there is no compelling clinical evidence on CQ, HCQ, and azithromycin in COVID-19 and the available evidence is limited to methodologically inferior non-randomised studies. Studies have also shown detrimental drug reactions to CQ and 'HCQ plus azithromycin', mainly cardiac side effects in hospitalised patients with coexisting cardiovascular comorbidities. Therefore, we recommend that physicians avoid high doses and exercise extreme caution in the compassionate use of CQ/HCQ, either alone or in combination with other antiviral drugs.

Keywords: COVID-19; chloroquine; evidence; hydroxychloroquine; review.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest statement: The authors declare that there is no conflict of interest.

References

    1. Liu Y, Gayle AA, Wilder-Smith A, et al. The reproductive number of COVID-19 is higher compared to SARS coronavirus. J Travel Med 2020; 27: taaa021. - PMC - PubMed
    1. Cascella M, Rajnik M, Cuomo A, et al. Features, evaluation and treatment coronavirus (COVID-19). In StatPearls, Treasure Island, FL: StatPearls Publishing, 2020. - PubMed
    1. Ciliberto G, Mancini R, Paggi MG. Drug repurposing against COVID-19: focus on anticancer agents. J Exp Clin Cancer Res 2020; 39: 86. - PMC - PubMed
    1. Cortegiani A, Ippolito M, Ingoglia G, et al. Chloroquine for COVID-19: rationale, facts, hopes. Crit Care 2020; 24: 210. - PMC - PubMed
    1. Browning DJ. Pharmacology of chloroquine and hydroxychloroquine. In: Hydroxychloroquine Chloroquine Retinopathy. Springer, New York, 2014, pp. 35–63.